A candidate gene approach to genetic contributors to the development of IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1020-1030

  Yamamoto, Ryohei ^a   Nagasawa, Yasuyuki ^a   Shoji, Tatsuya ^b   Katakami, Naoto ^a   Ohtoshi, Kentaro ^c   Hayaishi Okano, Rieko ^d   Yamasaki, Yoshimitsu ^a   Yamauchi, Atsushi ^a   Tsubakihara, Yoshiharu ^b   Imai, Enyu ^a   Rakugi, Hiromi ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c Otoshi Medical Clinic   (Japan)

^d OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Gene polymorphism; Iga nephropathy; Methionine synthase MTR A2756G (D919G)

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METHIONINE SYNTHASE GENE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEINURIA;

EID: 84861151033     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr369     Document Type: Article

References (51)

1. Nair R, Walker PD. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 2006; 69: 1455-1458
2. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron 1999; 82: 205-213
3. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727
4. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196
5. Hsu SI, Ramirez SB, Winn MP et al. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000; 57: 1818-1835
6. Paterson AD, Liu XQ, Wang K et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 2007; 18: 2408-2415
7. Bisceglia L, Cerullo G, Forabosco P et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet 2006; 79: 1130-1134
8. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 2000; 26: 354-357
9. Kiryluk K, Julian BA, Wyatt RJ et al. Genetic studies of IgA nephropathy: past, present, and future. Pediatr Nephrol 2010; 25: 2257-2268
10. Hiki Y, Odani H, TakahashiMet al. Mass spectrometry proves under- O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
11. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973
12. Narita I, Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin Exp Nephrol 2008; 12: 332-338
13. Hiki Y. O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol 2009; 13: 415-423
14. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760-769
15. Oortwijn BD, Roos A, Royle L et al. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 2006; 17: 3529-3539
16. Amore A, Conti G, Cirina P et al. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am J Kidney Dis 2000; 36: 1242-1252
17. Leung JC, Tang SC, Chan LY et al. Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA-role of MAPK and NF-kappaB. Nephrol Dial Transplant 2008; 23: 72-81
18. Lai KN, Tang SC, Guh JY et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the reninangiotensin system. J Am Soc Nephrol 2003; 14: 3127-3137
19. Leung JC, Tang SC, Chan LY et al. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 2003; 18: 36-45
20. Wang Y, Zhao MH, Zhang YK et al. Binding capacity and pathophysiological effects of IgA1 frompatientswith IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 2004; 136: 168-175
21. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513
22. Amore A, Cirina P, Conti G et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862-1871
23. Suzuki K, Honda K, Tanabe K et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63: 2286-2294
24. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008-1014
25. Lin X, Ding J, Zhu L et al. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant 2009; 24: 3372-3375
26. Coppo R, Camilla R, Amore A et al. Oxidative stress in IgA nephropathy. Nephron Clin Pract 2010; 116: c196-c199
27. Yamamoto R, Nagasawa Y, Shoji T et al. A candidate gene approach to genetic prognostic factors of IgA nephropathy-a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). Nephrol Dial Transplant 2009; 24: 3686-3694
28. Hayaishi-Okano R, Yamasaki Y, Ohtoshi K et al. NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjects. J Atheroscler Thromb 2002; 9: 200-205
29. Ohtoshi K, Yamasaki Y, Gorogawa S et al. Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 2002; 45: 1594-1601
30. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 2003; 26: 458-463
31. Yamada Y, Izawa H, Ichihara S et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-1923
32. Yamamoto R, Nagasawa Y, Shoji T et al. Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis 2010; 56: 313-324
33. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992
34. Stevens LA, Coresh J, Greene T et al. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483
35. Skol AD, Scott LJ, Abecasis GR et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-213
36. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90
37. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-2022
38. Ninomiya T, Kiyohara Y, Kubo M et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 2004; 44: 437-445
39. Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochemistry (Mosc) 2009; 74: 589-598
40. Harmon DL, Shields DC, Woodside JV et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 17: 298-309
41. Dekou V, Gudnason V, Hawe E et al. Gene-environment and genegene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost 2001; 85: 67-74
42. Chen J, Stampfer MJ, Ma J et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 154: 667-672
43. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748
44. Yang ZZ, Zou AP. Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells. Kidney Int 2003; 63: 1012-1020
45. Yi F, Zhang AY, Janscha JL et al. Homocysteine activates NADH/ NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 2004; 66: 1977-1987
46. Yi F, Zhang AY, Li N et al. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int 2006; 70: 88-96
47. Yi F, Xia M, Li N et al. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 2009; 53: 90-96
48. Zhang C, Yi F, Xia M et al. NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats. Antioxid Redox Signal 2010; 13: 975-986
49. Li GS, Zhang H, Lv JC et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 2007; 71: 448-453
50. Liu XQ, Paterson AD, He N et al. IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1025-1033
51. Woo KT, Lau YK, Choong LH et al. Polymorphism of reninangiotensin system genes in IgA nephropathy. Nephrology (Carlton) 2004; 9: 304-309